These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.
    Author: Leclerc JC, Cantor H.
    Journal: J Immunol; 1980 Feb; 124(2):851-4. PubMed ID: 6243333.
    Abstract:
    These studies demonstrate that two different types of protective immunologic reactions are generated in mice after inoculation with M.MSV. Type I protection, mediated by Ly1 cells, prevents MSV-induced sarcomas but has no effect on the growth of MLV+ lymphomas. This anti-MSV protection reflects induction of antivirion antibody and delayed type hypersensitivity reaction. Type II protection is mediated by Ly23 cells and prevents the growth of an MLV+ lymphoma, but has little or no protective effects against MSV-induced sarcomas. This "type II" reaction is directly related to CTL activity. The implications of these two protective reaction are discussed.
    [Abstract] [Full Text] [Related] [New Search]